News Sentiment

300204 sentiment intelligence

Staidson (Beijing) BioPharmaceuticals Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 56 Balanced news tone 3 relevant articles
Exchange SHZ China
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 24.50 Week of 17 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 3

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+1.2% over one week, +19.5% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Enterprise value to EBIT forward of Staidson (Beijing) Biopharmaceuticals Co. Ltd. Class A – SZSE:300204

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction 1.2% Price digesting
Trend fit Trend inactive 19.5% over four weeks
Fair value 41.2% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 2
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 3
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 2
MarketsMojo 1

Event Lens

What the news is about

Classified themes
Market update 3

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-3 of 3